WallStreetZenWallStreetZen

NASDAQ: CME
Cme Group Inc Stock

$175.68-1.09 (-0.62%)
Updated Jan 27, 2023
CME Price
$175.68
Fair Value Price
$182.70
Market Cap
$63.20B
52 Week Low
$166.55
52 Week High
$256.94
P/E
23.93x
P/B
2.24x
P/S
12.81x
PEG
3.35x
Dividend Yield
4.84%
Revenue
$4.96B
Earnings
$2.68B
Gross Margin
100%
Operating Margin
73.14%
Profit Margin
53.1%
Debt to Equity
5.32
Operating Cash Flow
$3B
Beta
0.78
Next Earnings
Feb 8, 2023
Ex-Dividend
N/A
Next Dividend
N/A

CME Overview

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.

Zen Score

Industry Average (38)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CME scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CME ($175.68) is undervalued by 3.84% relative to our estimate of its Fair Value price of $182.70 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
CME ($175.68) is not significantly undervalued (3.84%) relative to our estimate of its Fair Value price of $182.70 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CME ($175.68) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more CME due diligence checks available for Premium users.

Be the first to know about important CME news, forecast changes, insider trades & much more!

CME News

Valuation

CME fair value

Fair Value of CME stock based on Discounted Cash Flow (DCF)
Price
$175.68
Fair Value
$182.70
Undervalued by
3.84%
CME ($175.68) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CME ($175.68) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CME ($175.68) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CME price to earnings (PE)

For valuing profitable companies with steady earnings
Company
23.93x
Industry
33.73x
Market
23.59x
CME is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CME is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

CME price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.24x
Industry
4.11x
CME is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CME price to earnings growth (PEG)

For valuing profitable companies with growth potential
CME is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

CME's financial health

Profit margin

Revenue
$1.2B
Net Income
$679.6M
Profit Margin
54.7%
CME's Earnings (EBIT) of $3.63B... subscribe to Premium to read more.
Interest Coverage Financials
CME's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$178.4B
Liabilities
$150.2B
Debt to equity
5.32
CME's short-term assets ($143.25B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CME's short-term assets ($143.25B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CME's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CME's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$657.8M
Investing
-$23.6M
Financing
$1.2B
CME's operating cash flow ($2.74B)... subscribe to Premium to read more.
Debt Coverage Financials

CME vs Financial Datum & Stock Exchange Stocks

TickerMarket Cap1d %P/EP/B
CME$63.20B-0.62%23.93x2.24x
ICE$60.29B-0.23%23.78x2.69x
MCO$58.55B+0.43%37.95x25.96x
MSCI$41.57B+0.91%49.80x-38.59x
NDAQ$29.72B+0.65%26.19x5.06x

Cme Group Stock FAQ

What is Cme Group's quote symbol?

NASDAQ: CME) Cme Group trades on the NASDAQ under the ticker symbol CME. Cme Group stock quotes can also be displayed as NASDAQ: CME.

If you're new to stock investing, here's how to buy Cme Group stock.

What is the 52 week high and low for Cme Group (NASDAQ: CME)?

(NASDAQ: CME) Cme Group's 52-week high was $256.94, and its 52-week low was $166.55. It is currently -31.63% from its 52-week high and 5.49% from its 52-week low.

How much is Cme Group stock worth today?

(NASDAQ: CME) Cme Group currently has 359,726,266 outstanding shares. With Cme Group stock trading at $175.68 per share, the total value of Cme Group stock (market capitalization) is $63.20B.

Cme Group stock was originally listed at a price of $8.58 in Dec 6, 2002. If you had invested in Cme Group stock at $8.58, your return over the last 20 years would have been 1,947.55%, for an annualized return of 16.3% (not including any dividends or dividend reinvestments).

How much is Cme Group's stock price per share?

(NASDAQ: CME) Cme Group stock price per share is $175.68 today (as of Jan 27, 2023).

What is Cme Group's Market Cap?

(NASDAQ: CME) Cme Group's market cap is $63.20B, as of Jan 28, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Cme Group's market cap is calculated by multiplying CME's current stock price of $175.68 by CME's total outstanding shares of 359,726,266.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.